Syncom Formulations (India) Limited (BOM:524470)
13.19
+0.09 (0.69%)
At close: Jul 27, 2026
BOM:524470 Market Cap
BOM:524470 has a market cap or net worth of 12.4 billion as of July 28, 2026. Its market cap has decreased by -27.33% in one year.
Market Cap
12.40B
Enterprise Value
11.28B
Revenue
4.89B
Ranking
n/a
PE Ratio
16.28
Stock Price
13.19
ChartMarket Cap Chart
Since December 31, 2001, BOM:524470's market cap has increased from 267.05M to 12.40B, an increase of 4,542.83%. That is a compound annual growth rate of 16.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 12.40B | -7.57% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTK Healthcare | 15.30B |
| Amrutanjan Health Care | 14.85B |
| Fredun Pharmaceuticals | 14.80B |
| Shukra Pharmaceuticals | 13.94B |
| Fermenta Biotech | 12.40B |
| Lincoln Pharmaceuticals | 11.66B |
| Wanbury | 11.60B |
| Sudarshan Pharma Industries | 10.06B |